Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
Cancer Research Communications|March 2, 2023
Integrated, Longitudinal Analysis of Cell-free DNA in Uveal MelanomaDerek Wong, Ping Luo, Nadia Znassi, et al.
Ebiomedicine|December 9, 2025
Characterising the effect of circulating sphingolipids on metastatic prostate cancer cellsNeil Portman, Blossom Mak, Nicole Yeung, et al.
The Lancet. Oncology|October 19, 2022
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [<sup>177</sup>Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trialJames P Buteau, Andrew J Martin, Louise Emmett, et al.
Prostate Cancer|June 27, 2022
Expansion of Lymphocytes from Prostatic Adenocarcinoma and Adjacent Nonmalignant TissueLinh T Nguyen, Charlotte S Lo, Michael Fyrsta, et al.
Cancer|February 16, 2019
Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicitiesYada Kanjanapan, Daphne Day, Lisa Wang, et al.
Cancers|May 13, 2020
The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective AnalysisMegan Crumbaker, Eva K F Chan, Tingting Gong, et al.
NPJ Precision Oncology|September 9, 2024
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutationSubotheni Thavaneswaran, Frank Lin, John P Grady, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repairAlan Dal Pra, Emilie Lalonde, Jenna Sykes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2025
Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical TrialsJia Liu, Max Farrow, Lesley Seymour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET TrialSebastian Medina, Naoto Tokuyama, Vaishnavi Putcha, et al.
Pageof 20